Ireland· IE-PA-EU/1/21/1571/009-012
Abiraterone Mylan 1000 mg film-coated tablets
A abiraterone product containing abiraterone acetate, registered in Ireland by Mylan Pharmaceuticals Limited. The same ATC class is registered in 18 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Abiraterone is registered in 18 of 19 countries.
Countries holding a registration under ATC L02BX03 (abiraterone), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 10 of them publish a price we can compare per daily dose
Abiraterone · ATC L02BX03
18 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of abiraterone costs, country by country.
Normalised to the WHO defined daily dose (1 g), so markets compare like for like.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Abiraterone · price per daily dose (1 g)
USD · FX 28 Sept 2026
- CH Switzerland$42.72
- FR France$33.07
The record
At a glance
HPRA (Ireland)- Active substance
- Abiraterone acetate
- Manufacturer
- Mylan Pharmaceuticals Limited
- Country
- Ireland (IE)
- ATC code
- L02BX03
- ATC class
- Abiraterone
- Defined daily dose
- 1 g, O
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberEU/1/21/1571/009-012
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
461 interactions on record for abiraterone.
Graded by severity as the source publishes them — 101 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Abiraterone · interactions on record
461 records
- 101 severe
- 335 moderate
- 25 minor
Most severe, free to view
- PapaverineA03AD01severe
- CisaprideA03FA02severe
- DolasetronA04AA04severe
- LoperamideA07DA03severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Abiraterone in 17 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaABIRATERONE MYLANMylan Pharmaceuticals Limited, Dublin
- FinlandAbirateron SandozSandoz A/S
- NetherlandsAbirateron 1A Pharma 1000 mg, filmomhulde tabletten1A Pharma GmbH
- FranceABIRATERONE SANDOZ 1000 mg, comprimé pelliculéSANDOZ
- BelgiumAbiraterone Mylan 1000 mgMylan Pharmaceuticals
- SwitzerlandAbirateron Sandoz
- SpainABIRATERONA MYLAN 1000 MG COMPRIMIDOS RECUBIERTOS CON PELICULAMylan Ireland Limited
- PolandAbiraterone MylanMylan Pharmaceuticals Ltd
Authorised across Europe · EMA
The same active substance is authorised in 30 EEA countries. Names it is sold under:
- Austria · Abiral, Abirateron +pharma
- Belgium · Abirateron Eg, Abirateronacetaat Eg (Eurogenerics) Nv
- Bulgaria · Абиратерон Msn, Абиратерон Деватис
- Cyprus · Abiraterone Farmoz, Abiraterone Pharmazac
- Czechia · Abirateron Ashcure, Abirateron Pharmagen
- Germany · Abibam®, Abiranio
- Denmark · Abirateron "olpha", Abirateron "sandoz"
- Estonia · Abiraterone G.L. Pharma, Abiraterone Norameda
- Spain · Abiraterona Ashcure, Abiraterona Cipla
- Finland · Abirateron Avansor, Abirateron Devatis
- France · Abiraterone Acetate Zydus, Abiraterone Arrow
- United Kingdom (Northern Ireland) · Abiraterone, Abiraterone Abdi
- Greece · Abinone, Abiprostem
- Croatia · Abirateron Alpha-Medical, Abirateron Devatis
- Hungary · Abaxan, Abirateron Galenika
- Iceland · Abirateron, Abirateron Medical Valley
- Italy · Abiraterone Abdi, Abiraterone Abdi Farma
- Liechtenstein · Abiraterone Accord, Abiraterone Mylan
- Lithuania · Abiraterone G.L. Pharma, Abiraterone Norameda
- Luxembourg · Abirateron Eg, Abiraterone Eugia
- Latvia · Abiraterone G.L. Pharma, Abiraterone Norameda
- Malta · Abiraterone Ashcure, Abiraterone Clonmel
- Netherlands · Abirateron 1a Pharma, Abirateron Abdi
- Norway · Abirateron Devatis, Abirateron Medical Valley
- Poland · Abiral, Abirateron Sun
- Portugal · Abiraterona Bluepharma, Abiraterona Eugia
- Romania · Abirateron? Lannacher, Abirateronă
- Sweden · Abirateron Devatis, Abirateron Medical Valley
- Slovenia · Abirateron Galenika, Abirateron Teva
- Slovakia · Abirateron Msn, Abirateron Pharmagen
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/95a3202b-c31b-4825-abd8-9234c1b523a1 GET /v1/drugs/95a3202b-c31b-4825-abd8-9234c1b523a1?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Film-coated tablet",
"routes": [
"Oral use"
],
"source": "hpra",
"atc_all": [
"L02BX03"
],
"strength": null,
"pa_number": "EU/1/21/1571/009-012",
"substances": [
"Abiraterone acetate"
],
"legal_basis": "Hybrid application (Article 10(3) of Directive No 2001/83/EC)",
"market_info": "Unknown",
"authorised_at": "20/08/2021",
"dispensing_status": "Product subject to prescription which may not be renewed (A)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about abiraterone.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.